Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Bartsch

Showing results (91-100 of 111) with videos related to

Pageof 12
Sort By:
ESMO Open|March 25, 2022
Effect of concomitant statin treatment in postmenopausal patients with hormone receptor-positive early-stage breast cancer receiving adjuvant denosumab or placebo: a post hoc analysis of ABCSG-18C Minichsdorfer, T Fuereder, M Leutner, et al.
Archiv Der Pharmazie|August 18, 1999
New aminocarboxamides with class III anti-arrhythmic activityH Poppe, R Schindler, W Sauer, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 9, 2006
A single nucleotide polymorphism in the matrix metalloproteinase 9 gene (-8202A/G) is associated with thoracic aortic aneurysms and thoracic aortic dissectionLi Chen, Xinwen Wang, Stacey A Carter, et al.
NPJ Precision Oncology|December 20, 2024
Breast cancer brain metastases genomic profiling identifies alterations targetable by immune-checkpoint and PARP inhibitorsA Giannoudis, E S Sokol, T Bhogal, et al.
British Journal of Cancer|October 11, 2012
Brain-only metastatic breast cancer is a distinct clinical entity characterised by favourable median overall survival time and a high rate of long-term survivorsA S Berghoff, Z Bago-Horvath, A Ilhan-Mutlu, et al.
British Journal of Cancer|December 1, 2011
Impact of anti-HER2 therapy on overall survival in HER2-overexpressing breast cancer patients with brain metastasesR Bartsch, A Berghoff, U Pluschnig, et al.
Breast Cancer Research and Treatment|April 25, 2016
Prognostic impact of breast cancer subtypes in elderly patientsE S Bergen, C Tichy, A S Berghoff, et al.
British Journal of Cancer|September 30, 2010
Modulation of plasma complement by the initial dose of epirubicin/docetaxel therapy in breast cancer and its predictive valueA Michlmayr, T Bachleitner-Hofmann, S Baumann, et al.
European Journal of Cancer Care|May 11, 2017
Decreased body mass index is associated with impaired survival in lung cancer patients with brain metastases: A retrospective analysis of 624 patientsE K Masel, A S Berghoff, L M Füreder, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 30, 2026
Metastatic breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up<sup>†</sup>E de Azambuja, C H Barrios, R Bartsch, et al.
Pageof 12

Showing results (91-100 of 111) with videos related to

Sort By:
Pageof 12
ESMO Open|March 25, 2022
Effect of concomitant statin treatment in postmenopausal patients with hormone receptor-positive early-stage breast cancer receiving adjuvant denosumab or placebo: a post hoc analysis of ABCSG-18C Minichsdorfer, T Fuereder, M Leutner, et al.
Archiv Der Pharmazie|August 18, 1999
New aminocarboxamides with class III anti-arrhythmic activityH Poppe, R Schindler, W Sauer, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 9, 2006
A single nucleotide polymorphism in the matrix metalloproteinase 9 gene (-8202A/G) is associated with thoracic aortic aneurysms and thoracic aortic dissectionLi Chen, Xinwen Wang, Stacey A Carter, et al.
NPJ Precision Oncology|December 20, 2024
Breast cancer brain metastases genomic profiling identifies alterations targetable by immune-checkpoint and PARP inhibitorsA Giannoudis, E S Sokol, T Bhogal, et al.
British Journal of Cancer|October 11, 2012
Brain-only metastatic breast cancer is a distinct clinical entity characterised by favourable median overall survival time and a high rate of long-term survivorsA S Berghoff, Z Bago-Horvath, A Ilhan-Mutlu, et al.
British Journal of Cancer|December 1, 2011
Impact of anti-HER2 therapy on overall survival in HER2-overexpressing breast cancer patients with brain metastasesR Bartsch, A Berghoff, U Pluschnig, et al.
Breast Cancer Research and Treatment|April 25, 2016
Prognostic impact of breast cancer subtypes in elderly patientsE S Bergen, C Tichy, A S Berghoff, et al.
British Journal of Cancer|September 30, 2010
Modulation of plasma complement by the initial dose of epirubicin/docetaxel therapy in breast cancer and its predictive valueA Michlmayr, T Bachleitner-Hofmann, S Baumann, et al.
European Journal of Cancer Care|May 11, 2017
Decreased body mass index is associated with impaired survival in lung cancer patients with brain metastases: A retrospective analysis of 624 patientsE K Masel, A S Berghoff, L M Füreder, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 30, 2026
Metastatic breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up<sup>†</sup>E de Azambuja, C H Barrios, R Bartsch, et al.
Pageof 12